The Bluerockers have started

The Bluerockers have started
# # # # On the 8th June, BlueRock Therapeutics put out a press release announcing that the first participant in their Phase I clinical trial of cell transplantation for Parkinson’s had been dosed (Click here to read the press release). The initiation of this clinical trial by the company is a major step forward for them and ... read more
Source: The Science of Parkinson’s diseasePublished on 2021-07-15By Simon